This statistic displays the top pharmaceutical R&D projects based on net present value, as of December 2024. According to the source, the top R&D project was Novo Nordisk's fixed-dose combination for type 2 diabetes and obesity Cagrisema, with a net present value of over 87 billion U.S. dollars at that time.
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Everything on "Top pharmaceutical drugs" in one document: edited and divided into chapters, including detailed references.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Overview
R&D performance by company
Characteristics of R&D pipeline
Duration, cost and ROI
Outsourced R&D
Public opinion/knowledge
Further related statistics
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
